ROHIT BHATIA | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

ISF College of Pharmacy Moga, India

Author Profile

Early Academic Pursuits

Dr. Rohit Bhatia embarked on his academic journey with a B. Pharmacy degree from HP University, graduating with an impressive 75.5% in 2011. Building on this foundation, he pursued a Master's in Pharmacy in Pharmaceutical Chemistry from PTU University, securing a notable 74.5% in 2013. His academic pursuit culminated in a Ph.D. in Pharmaceutical Sciences from MRSPTU, Bathinda, in 2022, showcasing his dedication to advancing in the field.

Professional Endeavors

HIs professional career is marked by significant milestones. He served as an Assistant Professor of Pharmaceutical Chemistry at Laureate Institute of Pharmacy from 2013 to 2016 before transitioning to his current role as an Associate Professor at ISF College of Pharmacy from 2016 to the present. His roles have involved guiding numerous M. Pharm and Ph.D. students, totaling 27 and 3, respectively, showcasing his commitment to mentorship and education in the pharmaceutical field.

Contributions and Research Focus

With a keen interest in drug design and molecular modeling, His contributed significantly to pharmaceutical sciences. His research projects, including the synthesis and evaluation of coumarin fused/tethered nitrogen-containing heterocycles as anticancer agents and work on imidazo [2,1-b] [1,3,4] thiadiazole derivatives, highlight his expertise in synthetic medicinal chemistry and target-based drug design. Furthermore, his focus on analytical method development and bioanalysis, along with microfluidics-based analysis, underscores his multidisciplinary approach to research.

Accolades and Recognition

His contributions have been widely recognized through various grants, awards, and achievements. Notable among these are the MSME grant for developing an electrochemical device for detecting glucose levels in human saliva, received in 2022. His innovative teaching methods earned him the Best Innovative Teacher Award in Pharmaceutical Analysis at the National Pharma Summit-2023. Additionally, he has consistently won prizes and awards for his research presentations, such as the Pharma Rising Star Award and recognition for his work in repurposing drugs against SARS-CoV-2.

Impact and Influence

His work has made a tangible impact on the pharmaceutical landscape, evident from his patents and copyrights. His patents range from techniques for quantifying ascorbic acid to novel drug delivery systems and neuroprotective compounds, showcasing his diverse contributions to the field. Furthermore, his involvement in national and international conferences, along with his role as a Bentham Ambassador, speaks volumes about his influence and standing within the scientific community.

Legacy and Future Contributions

His continues to excel in academia and research, his legacy as a mentor, innovator, and contributor to pharmaceutical sciences is firmly established. His future contributions are anticipated to further push the boundaries of drug design, analytical techniques, and therapeutic innovations. Through his continued dedication to education, research, and impactful collaborations, His  is poised to leave a lasting imprint on the field of pharmaceutical sciences.

Notable Publications 

Synthetic and medicinal perspective of thiazolidinones: A review

Drug metabolizing enzymes and their inhibitors' role in cancer resistance

Inductively coupled plasma optical emission spectrometry (ICP-OES): a powerful analytical technique for elemental analysis

Applications of various analytical techniques in quality control of pharmaceutical excipients

Design, synthesis and neuropharmacological evaluation of new 2, 4-disubstituted-1, 5-benzodiazepines as CNS active agents

Protein tyrosine phosphatase (PTP1B): a promising drug target against life-threatening ailments

based microfluidic devices: Fabrication, detection, and significant applications in various fields

Recent advancements in anti-leishmanial research: Synthetic strategies and structural activity relationships

Enasidenib: first mutant IDH2 inhibitor for the treatment of refractory and relapsed acute myeloid leukemia

Design, synthesis, biological evaluation, and molecular modeling studies of rhodanine derivatives as pancreatic lipase inhibitors

ROHIT BHATIA | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

You May Also Like